Skip to main content

Engelson Erik T.'s Form 4 filing

Lucira Health, Inc. (LHDX) · filed Mar 13, 2023

Accession no.
0001209191-23-018261
Filed
Mar 13, 2023
Trade date
Mar 3, 2023
Filing delay
10 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $657.3K. It was filed 10 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Engelson Erik T.CIK 0001839384Director, Officer (President and Chief Executive)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2023Common StockMOption exerciseAcquired+574,666$0.82+$471,226.12657,948Direct
Mar 3, 2023Common StockSSaleDisposed−574,666$1.03−$591,905.9883,282Direct
Mar 3, 2023Common StockSSaleDisposed−60,000$1.09−$65,40023,282Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 3, 2023Common StockMOption exerciseDisposed−574,666$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)